Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/24/2008US7390484 Self-contained adipose derived stem cell processing unit
06/24/2008US7390432 A formulation for use in neutralization of at least one toxant containing a cationic surfactant and a cationic hydrotrope as solubilizing compounds, a peroxy reactive compound, and a bleaching activator
06/24/2008US7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
06/19/2008WO2008074036A2 Eye medication formulation with antibacterial agent
06/19/2008WO2008074033A1 Compositions and methods of using (r)-pramipexole
06/19/2008WO2008074001A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients
06/19/2008WO2008073987A1 Saturated fused [1,2-b] pyridazinone compounds
06/19/2008WO2008073982A2 5,6-dihydro-1h-pyridin-2-one compounds
06/19/2008WO2008073961A2 Compounds and methods for modulating the silencing of a polynucleotide of interest
06/19/2008WO2008073958A2 Substituted benzothiadiazinedioxide derivatives and methods of their use
06/19/2008WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use
06/19/2008WO2008073943A1 Dihydrobenzofuranyl derivatives and methods of their use
06/19/2008WO2008073942A2 Pharmaceutical compositions and their methods of use
06/19/2008WO2008073936A1 Carboxamide derivatives as ion channel modulators
06/19/2008WO2008073934A1 Ion channel modulators
06/19/2008WO2008073929A1 Ion channel modulators
06/19/2008WO2008073928A1 Composition for treating a pulmonary hypertension
06/19/2008WO2008073927A1 Ambrisentan combined with a renin inhibitor for hypertensive disorder
06/19/2008WO2008073923A2 Mirna regulated genes and pathways as targets for therapeutic intervention
06/19/2008WO2008073918A1 Non-standard amino acid conjugates of amphetamine and processes for making and using the same
06/19/2008WO2008073865A2 Method of preventing or treating myocardial ischemia
06/19/2008WO2008073863A2 Preparation and utility of substituted allylamines
06/19/2008WO2008073858A2 Cancer chemoprevention strategy based on loss of imprinting of igf2
06/19/2008WO2008073825A1 Lxr and fxr modulators
06/19/2008WO2008073789A1 Ampa receptor potentiators
06/19/2008WO2008073785A2 Phosphoinositide 3-kinase inhibitor compounds and methods of use
06/19/2008WO2008073779A2 Compositions and methods for treating seizures
06/19/2008WO2008073770A1 Use of pkc inhibitors in transplantation
06/19/2008WO2008073759A2 An article comprising prasugrel
06/19/2008WO2008073757A1 Crystalline and amorphous forms of palonosetron hydrochloride
06/19/2008WO2008073752A2 Cyclobutyl derivatives for the treatment of glaucoma
06/19/2008WO2008073733A1 Salts of inhibitors of histone deacetylase for the treatment of disease
06/19/2008WO2008073731A2 Microemulsion dosage forms of valsartan and methods of making the same
06/19/2008WO2008073684A1 Composition for treating aging skin comprising a hydroxycinnamic acid such as p-coumaric acid
06/19/2008WO2008073670A2 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
06/19/2008WO2008073623A2 Soluble epoxide hydrolase inhibitors
06/19/2008WO2008073614A2 Composition and method for enhancing skin cell growth, proliferation and repair
06/19/2008WO2008073480A1 Compounds and compositions as kinase inhibitors
06/19/2008WO2008073479A2 Anticonnexin polynucleotides as impaired wound healing compositions
06/19/2008WO2008073466A2 Alpha b-crystallin as a therapy for inflammation
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008WO2008073452A1 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
06/19/2008WO2008073450A2 Benzamide compounds
06/19/2008WO2008073381A2 Synergistic effects of combinations of nornicotine and opioids for the treatment of pain
06/19/2008WO2008073370A1 Aspartyl protease inhibitors containing a tricyclic ring system
06/19/2008WO2008073365A1 Aspartyl protease inhibitors
06/19/2008WO2008073344A1 Acetaminophen compositions having minimized side effects including reduced hepatotoxicity
06/19/2008WO2008073324A1 Topical eutectic anesthetic composition for oral or dermal tissue
06/19/2008WO2008073318A2 Use of atp in controlled regional reperfusion as treatment during acute myocardial infarction
06/19/2008WO2008073306A1 Organic compounds
06/19/2008WO2008073282A2 Ph sensitive matrix formulation
06/19/2008WO2008073257A1 Use of prodrugs of gaba analogs for treating diseases
06/19/2008WO2008073251A1 Constrained spirocyclic compounds as cgrp receptor antagonists
06/19/2008WO2008073231A1 Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4, 3-b) indoles (variants), pharmacological means based thereon and method for the use thereof
06/19/2008WO2008073230A1 Liposome containing cardiolipin for improvement of mitochondrial function
06/19/2008WO2008073138A2 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors
06/19/2008WO2008073130A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors
06/19/2008WO2008073125A1 Moxonidine analogs, preparation processes and uses therefor
06/19/2008WO2008073067A1 Novel spiro-quinuclidinyl derivatives for the treatment of the central nervous system disorders
06/19/2008WO2008072954A2 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
06/19/2008WO2008072953A1 Statin containing compositions for treatment of cancer
06/19/2008WO2008072952A2 Anti-inflammatory compounds containing compositions for treatment of cancer
06/19/2008WO2008072941A1 Compositions comprising compounds of natural origin for damaged skin
06/19/2008WO2008072937A1 Pharmaceutical composition, health food composition and inos inhibitors, containing theopederin derivatives
06/19/2008WO2008072905A1 Composition comprising hyaluronic acid and/or its salts for treatment of atopic dermatitis
06/19/2008WO2008072855A1 Pharmaceutical composition for obovatol for the prevention and treatment of restenosis
06/19/2008WO2008072850A1 Triazine derivatives having inhibitory activity against acetyl-coa carboxylase
06/19/2008WO2008072836A1 Inclusion complex comprising clopidogrel
06/19/2008WO2008072799A1 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof
06/19/2008WO2008072784A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
06/19/2008WO2008072779A1 Quinoxaline derivative
06/19/2008WO2008072778A1 Therapeutic agent for urinary tract disease
06/19/2008WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008WO2008072725A1 Composition containing agaricus blazei murill
06/19/2008WO2008072724A1 Pyrazole derivative
06/19/2008WO2008072703A1 Biphenylamide derivative
06/19/2008WO2008072682A1 Imidazo[1,2-b]pyridazine derivative
06/19/2008WO2008072663A1 Composition for amelioration/prevention of adverse side effect in steroid therapy
06/19/2008WO2008072658A1 2-phenylnicotinic acid derivative
06/19/2008WO2008072655A1 Imidazothiazole derivatives
06/19/2008WO2008072634A1 Fused heterocyclic compound
06/19/2008WO2008072591A1 Iron metabolism-improving agent
06/19/2008WO2008072584A1 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome
06/19/2008WO2008072535A1 Pharmaceutical composition containing low-substituted hydroxypropylcellulose
06/19/2008WO2008072534A1 Solid medicinal preparation containing mannitol or lactose
06/19/2008WO2008072533A1 Method for producing solid preparation
06/19/2008WO2008072532A1 Pharmaceutical composition having improved storage stability
06/19/2008WO2008072385A1 Therapeutic agent for disease caused by accumulation of body fat
06/19/2008WO2008072360A1 Catechin composition and method for producing the same
06/19/2008WO2008072206A2 Composition comprising pyrithione or a polyvalent metal salt of a pyrithione and furametpyr
06/19/2008WO2008072190A2 Compositions of azimilide dihydrochloride
06/19/2008WO2008072079A2 Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
06/19/2008WO2008072077A2 Combination of 1-aryl-4-cyclopropylpyrazoles with anthelmintic agent for parasitic infestation
06/19/2008WO2008072072A1 Terminally unsaturated vanilloids and medicinal application thereof
06/19/2008WO2008072061A1 Method of treatment of obesity with an mtp inhibitor in conjunction with an increased-fat diet
06/19/2008WO2008072056A1 Use of mtp inhibitors for the treatment of obesity using low doses and dose-escalation
06/19/2008WO2008072034A1 Macrolide compounds endowed with antiinflammatory activity
06/19/2008WO2008072018A1 Improved method for making analgesics
06/19/2008WO2008071991A1 Treatment of pervasive developmental disorders
06/19/2008WO2008071980A1 Novel aminoguanidines as melanocortin receptor ligands.
1 ... 3211 3212 3213 3214 3215 3216 3217 3218 3219 3220 3221 3222 3223 3224 3225 3226 3227 3228 3229 3230 3231 ... 7860